OBJECTIVES: Persistent cognitive impairment (PCI) after remission of depressive symptoms is a major adverse outcome of late-life depression (LLD). The purpose of this study was to examine neural substrates associated with PCI in LLD. DESIGN: Longitudinal study. SETTING: Outpatient depression treatment study at Duke University. PARTICIPANTS: Twenty-three patients with LLD completed a 2-year follow-up study, and were in a remitted or partially remitted state at Year 2. METHODS: At first entry to the study (Year 0), all participants had a functional magnetic resonance imaging scan while performing an emotional oddball task. For the purpose of this report, the primary functional magnetic resonance imaging outcome was brain activation during target detection, which is a measure of executive function. The Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery was used to assess cognitive status yearly, and the Montgomery-Åsberg Depression Rating Scale was used to assess severity of depression at Year 0 and every 6 months thereafter for 2 years. We investigated changes in brain activation at Year 0 associated with PCI over 2 years. RESULTS: Patients with PCI at the 2-year follow-up date had significantly decreased activation at Year 0 in the dorsal anterior cingulate cortex, hippocampus, inferior frontal cortex, and insula compared to non-PCI patients. CONCLUSIONS: Our results suggest individuals who have LLD with PCI have decreased activation in the similar neural networks associated with the development of Alzheimer disease among nondepressed individuals. Measuring neural activity in these regions in individuals with LLD may help identify patients at-risk for cognitive impairment.
OBJECTIVES: Persistent cognitive impairment (PCI) after remission of depressive symptoms is a major adverse outcome of late-life depression (LLD). The purpose of this study was to examine neural substrates associated with PCI in LLD. DESIGN: Longitudinal study. SETTING:Outpatientdepression treatment study at Duke University. PARTICIPANTS: Twenty-three patients with LLD completed a 2-year follow-up study, and were in a remitted or partially remitted state at Year 2. METHODS: At first entry to the study (Year 0), all participants had a functional magnetic resonance imaging scan while performing an emotional oddball task. For the purpose of this report, the primary functional magnetic resonance imaging outcome was brain activation during target detection, which is a measure of executive function. The Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery was used to assess cognitive status yearly, and the Montgomery-Åsberg Depression Rating Scale was used to assess severity of depression at Year 0 and every 6 months thereafter for 2 years. We investigated changes in brain activation at Year 0 associated with PCI over 2 years. RESULTS:Patients with PCI at the 2-year follow-up date had significantly decreased activation at Year 0 in the dorsal anterior cingulate cortex, hippocampus, inferior frontal cortex, and insula compared to non-PCI patients. CONCLUSIONS: Our results suggest individuals who have LLD with PCI have decreased activation in the similar neural networks associated with the development of Alzheimer disease among nondepressed individuals. Measuring neural activity in these regions in individuals with LLD may help identify patients at-risk for cognitive impairment.
Authors: M J Chandler; L H Lacritz; L S Hynan; H D Barnard; G Allen; M Deschner; M F Weiner; C M Cullum Journal: Neurology Date: 2005-07-12 Impact factor: 9.910
Authors: Lihong Wang; Kevin S LaBar; Moria Smoski; M Zachary Rosenthal; Florin Dolcos; Thomas R Lynch; Ranga R Krishnan; Gregory McCarthy Journal: Psychiatry Res Date: 2008-05-01 Impact factor: 3.222
Authors: Lihong Wang; K Ranga Krishnan; David C Steffens; Guy G Potter; Florin Dolcos; Gregory McCarthy Journal: Am J Psychiatry Date: 2008-05-01 Impact factor: 18.112
Authors: Meryl A Butters; William E Klunk; Chester A Mathis; Julie C Price; Scott K Ziolko; Jessica A Hoge; Nicholas D Tsopelas; Brian J Lopresti; Charles F Reynolds; Steven T DeKosky; Carolyn C Meltzer Journal: Alzheimer Dis Assoc Disord Date: 2008 Jul-Sep Impact factor: 2.703
Authors: David A Wolk; Julie C Price; Judy A Saxton; Beth E Snitz; Jeffrey A James; Oscar L Lopez; Howard J Aizenstein; Ann D Cohen; Lisa A Weissfeld; Chester A Mathis; William E Klunk; Steven T De-Kosky; Steven T DeKoskym Journal: Ann Neurol Date: 2009-05 Impact factor: 10.422
Authors: Rishi K Bhalla; Meryl A Butters; James T Becker; Patricia R Houck; Beth E Snitz; Oscar L Lopez; Howard J Aizenstein; Ketki D Raina; Steven T DeKosky; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2009-04 Impact factor: 4.105
Authors: Howard J Aizenstein; Meryl A Butters; Minjie Wu; Laura M Mazurkewicz; V Andrew Stenger; Peter J Gianaros; James T Becker; Charles F Reynolds; Cameron S Carter Journal: Am J Geriatr Psychiatry Date: 2009-01 Impact factor: 4.105
Authors: Meryl A Butters; Jeffrey B Young; Oscar Lopez; Howard J Aizenstein; Benoit H Mulsant; Charles F Reynolds; Steven T DeKosky; James T Becker Journal: Dialogues Clin Neurosci Date: 2008 Impact factor: 5.986
Authors: Wenjun Li; B Douglas Ward; Chunming Xie; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: J Psychiatr Res Date: 2015-09-09 Impact factor: 4.791
Authors: Laurel D Pellegrino; Matthew E Peters; Constantine G Lyketsos; Christopher M Marano Journal: Curr Psychiatry Rep Date: 2013-09 Impact factor: 5.285
Authors: Nancy J Donovan; Rebecca E Amariglio; Amy S Zoller; Rebecca K Rudel; Teresa Gomez-Isla; Deborah Blacker; Bradley T Hyman; Joseph J Locascio; Keith A Johnson; Reisa A Sperling; Gad A Marshall; Dorene M Rentz Journal: Am J Geriatr Psychiatry Date: 2014-02-26 Impact factor: 4.105
Authors: Carmen Andreescu; Olusola Ajilore; Howard J Aizenstein; Kimberly Albert; Meryl A Butters; Bennett A Landman; Helmet T Karim; Robert Krafty; Warren D Taylor Journal: Am J Geriatr Psychiatry Date: 2019-08-07 Impact factor: 4.105